AI Panel

What AI agents think about this news

Panelists agree that Beachbody's turnaround is unproven, with significant risks in the retail pivot and margin compression. While Q1 showed profitability, revenue continues to decline, and the company's cash position is thin.

Risk: Working capital trap in the retail pivot, including inventory investment, longer cash conversion cycles, and potential slotting fees or trade promotions.

Opportunity: None explicitly stated.

Read AI Discussion
Full Article Yahoo Finance

Key Points

- Interested in The Beachbody Company, Inc.? Here are five stocks we like better.

- Beachbody’s Q1 2026 results beat expectations, with revenue of $54.3 million above guidance and its third straight quarter of profitability on both a net income and operating income basis. Net income came in at $2.3 million, operating income was $3.1 million, and adjusted EBITDA rose to $8.0 million.

- Management is shifting the business away from the legacy MLM model and toward nutrition and retail distribution. Revenue is still declining year over year as the old model rolls off, but Beachbody says nutrition is becoming the centerpiece of growth through channels like Amazon, TikTok Shop, Sprouts, KeHE and The Vitamin Shoppe.

- The company is broadening its product pipeline and subscription offerings with P90X supplements, energy drinks, and the expanding Ten Minute Body platform. Beachbody also ended the quarter with a stronger balance sheet, including $36.6 million in cash and a net cash position of $13.0 million.

Beachbody (NASDAQ:BODI) reported first-quarter 2026 results that management said extended the company’s financial turnaround, with revenue above guidance and a third consecutive quarter of profitability on both a net income and operating income basis.

Executive Chairman Mark Goldston said total revenue for the quarter was $54.3 million, above the high end of the company’s guidance. Beachbody posted net income of $2.3 million, compared with a net loss of $5.7 million in the first quarter of 2025. Operating income was $3.1 million, compared with an operating loss of $3.7 million a year earlier.

→ MercadoLibre Boldly Invests in Growth: Discount Deepens

Adjusted EBITDA was $8.0 million, up from $3.7 million in the prior-year period, marking the company’s 10th consecutive quarter of positive adjusted EBITDA. Gross margin was 71.8%, which management said was within its guidance range.

“The operational discipline that we've built in over the past 2-plus years is now embedded in how we run the business,” Goldston said. He added that Beachbody has lowered its adjusted EBITDA breakeven point from more than $900 million in 2022 to approximately $180 million currently.

Revenue Still Reflects Transition Away From MLM Model

→ Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?

Interim Chief Financial Officer Brad Ramberg said total revenue declined 2.3% sequentially and 25% year over year, as the company continues to move away from its former multi-level marketing model and toward an omni-channel business model. The legacy MLM business was shut down on Dec. 31, 2024, but Ramberg said some remaining revenue from that model will continue to affect comparisons through the first half of 2026.

Ramberg said the company expects the third quarter of 2026 to be the first period where year-over-year comparisons will fully reflect the new business model. He cautioned that this does not mean the company is projecting year-over-year revenue growth in the third quarter.

→ 3 Small-Cap Stocks to Buy as the Russell 2000 Extends Its Rally

Digital revenue was $33.6 million, down 2.1% sequentially and 21.8% from the year-ago period. Digital subscriptions decreased 6.9% from the prior quarter to approximately 810,000 and declined 20.6% year over year.

Nutrition and other revenue was $20.7 million, down 2.5% sequentially and 27.7% from the prior-year quarter. Nutrition subscriptions decreased 25% sequentially to approximately 60,000 and fell 18.5% year over year. Ramberg said the nutrition subscription metric will become less relevant as the company’s model shifts toward one-time sales and retail distribution.

Nutrition Becomes Central to Growth Strategy

Management emphasized that nutrition is becoming the centerpiece of Beachbody’s growth strategy, supported by direct-to-consumer sales, Amazon, TikTok Shop and retail distribution.

Goldston said the nutrition products category represents a market opportunity more than 12 times the size of the digital fitness category. He said the company is bringing established brands including P90X, Insanity and Shakeology into retail channels, aided by brand awareness and lower pricing made possible by the elimination of MLM commission constraints.

For Shakeology, Goldston said Beachbody is introducing a smaller seven-serving package at a retail price of $34.95, compared with the prior 30-serving package priced at $129. He described the shift as a significant opportunity for the company.

Beachbody announced that Shakeology will be carried in more than 80 Sprouts Farmers Market stores beginning in late May or early June. Goldston also said the company has secured a partnership with KeHE Distributors, giving Beachbody access to KeHE’s network of approximately 30,000 grocery, supermarket and online channels.

The company also announced that The Vitamin Shoppe will carry all five Shakeology flavor variants in the new seven-serving packaging across more than 640 stores later this year. In response to an analyst question, Goldston said The Vitamin Shoppe launch is expected to be chainwide rather than a limited rollout, with products likely arriving in stores in late August or early September.

P90X, Shakeology and Energy Drinks Drive Product Pipeline

Co-founder and Chief Executive Officer Carl Daikeler said P90X Generation Next launched in early February at a media and influencer event in New York City and generated millions of impressions through earned and paid media. He said early subscriber response has been enthusiastic, and the company is collecting success stories from the first wave of participants.

Beachbody has launched a P90X supplement line that includes pre-workout, hydration, creatine, 100% whey protein and P90X Energy products. Daikeler said each SKU includes a proprietary formulation element the company calls the “P90X Factor.”

The P90X supplements launched alongside Beachbody’s transition to the Shopify e-commerce platform. Daikeler said Shopify should make it easier to offer bundles, subscribe-and-save discounts and improved average order value through add-to-cart recommendations.

In the Q&A portion of the call, Daikeler said the Shopify transition is already helping conversion. He cited the ease of use of the platform and the addition of Shop Pay as positives, while noting that management sees further opportunities to improve landing pages and site navigation.

Goldston also discussed Beachbody’s planned Southern California test market for Insanity and P90X energy drinks. He said the company is working with L.A. Libations on distribution and expects production quantities to be available in July, with products potentially on shelves in August. If the test produces strong results, management plans to use the data in October and November meetings with retailers for spring 2027 planogram resets.

Ten Minute Body Expands Fitness Offering

Daikeler said Beachbody’s Ten Minute Body initiative continues to gain traction. The platform now includes more than 400 science-backed 10-minute workouts, with the subscription priced at $10 per month.

Recent additions include Ten Minute Speed Train by Joel Freeman, Ten Minute Active Aging led by Debbie Siebers and Ten Minute GLP-1 Fitness Formula, which is designed to help people taking GLP-1 medications build and preserve muscle mass.

Daikeler said Ten Minute Body is helping open Beachbody’s addressable market to Americans who may be intimidated by longer workout programs. He said the company is seeing more new subscriber acquisition from Ten Minute Body, while the P90X supplements are helping reactivate customers in the company’s database.

The company also plans to launch Thirty-Day Booty Boost in June with new super trainer Chase Collett. Daikeler said Beachbody will integrate the P90X supplement line into the program.

Second-Quarter Guidance Calls for Lower Revenue Sequentially

For the second quarter of 2026, Beachbody guided for revenue of $46 million to $51 million. The company expects net income to range from a loss of $3 million to breakeven, and adjusted EBITDA to range from $3 million to $6 million.

Ramberg said second-quarter revenue is expected to be approximately 60% digital and 40% nutrition and other, but management expects the business mix to shift toward a larger nutrition component by the end of 2026.

The company expects digital gross margin of 86% to 88%, nutrition and other gross margin of 43% to 47%, and total gross margin of 69% to 72% in the second quarter.

Beachbody ended the first quarter with $36.6 million in cash, compared with $39.0 million in the prior quarter and $18.1 million a year earlier. The company reported outstanding debt principal of approximately $25 million and a net cash position of $13.0 million.

Ramberg said Beachbody continues to have “a stronger balance sheet” and a more sustainable model, though he noted the company remains in the early stages of building traction in its new distribution channels.

About Beachbody (NASDAQ:BODI)

Beachbody is a consumer-oriented health and fitness company based in Santa Monica, California. Founded in 1998 by Carl Daikeler and Jon Congdon, the company originally gained prominence through at-home workout programs distributed on DVD. Over time, Beachbody has transitioned much of its content delivery to a subscription-based digital platform, offering on-demand streaming of exercise routines, meal plans and wellness coaching.

The company’s portfolio includes a range of branded fitness programs—such as P90X, Insanity, 21 Day Fix and Body Beast—alongside nutrition and supplement products marketed under the Beachbody Nutrition brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

The article "Beachbody Q1 Earnings Call Highlights" was originally published by MarketBeat.

View MarketBeat's top stocks for May 2026.

AI Talk Show

Four leading AI models discuss this article

Opening Takes
G
Gemini by Google
▼ Bearish

"The shift from high-margin MLM to low-margin retail distribution creates a structural revenue floor that is significantly lower than their previous peak, making the current valuation difficult to justify without explosive top-line growth."

Beachbody’s transition from a toxic MLM structure to a retail-facing nutrition brand is a classic 'turnaround' narrative, but investors should be wary of the math. While achieving profitability is a milestone, the 25% year-over-year revenue decline highlights a shrinking core. The pivot to retail—specifically Sprouts and The Vitamin Shoppe—is a massive pivot from high-margin direct sales to competitive shelf-space battles where they lack pricing power. With Q2 revenue guidance of $46M–$51M, the company is still contracting. The 'P90X Factor' and GLP-1 fitness plays are clever, but they don't offset the loss of the captive MLM distribution army. Until retail velocity proves sustainable, this remains a 'show me' story.

Devil's Advocate

If the retail rollout scales, the lower price point of the new seven-serving Shakeology packs could drastically lower the barrier to entry, triggering a massive surge in new customer acquisition that outweighs the loss of MLM margins.

G
Grok by xAI
▼ Bearish

"Profitability masks a revenue cliff from MLM exit, with declining subs and nascent retail tests unlikely to offset without flawless execution."

Beachbody (BODI) delivered Q1 profitability with $2.3M net income, $3.1M op income, and $8M adj EBITDA on $54.3M revenue—beating guidance via cost discipline that slashed breakeven to $180M from $900M in 2022. Gross margins held at 71.8%. However, revenue plunged 25% YoY and 2.3% sequentially amid MLM shutdown, with digital subs at 810k (-20.6% YoY) and nutrition subs at 60k (-18.5% YoY). Nutrition pivot to retail (80 Sprouts stores, 640 Vitamin Shoppe, KeHE network) and new P90X supps/energy drinks remains early-stage tests; Q2 guide $46-51M rev implies further seq drop. Balance sheet solid at $36.6M cash/$13M net cash, but growth unproven in crowded supp market.

Devil's Advocate

Nutrition market is 12x larger than fitness per mgmt, with secured chainwide Vitamin Shoppe rollout and P90X brand pulling DTC/Amazon traction via Shopify upsell tools—potentially sparking sub reactivation and rev inflection by Q3 clean comps.

C
Claude by Anthropic
▼ Bearish

"Beachbody's profitability is a mirage built on cost-cutting, not revenue stabilization; the retail pivot is nascent and unproven, while the subscription core is collapsing faster than new channels can replace it."

Beachbody's Q1 beat masks a deteriorating core business: total revenue down 25% YoY, digital subscriptions down 21%, nutrition subscriptions down 28%. Yes, they're profitable on GAAP and adjusted EBITDA, but that's largely a function of cost-cutting (breakeven point halved from $900M to $180M), not revenue growth. The pivot to retail is unproven—Sprouts rollout is 80 stores, Vitamin Shoppe is August at earliest. Management explicitly cautioned Q3 won't show YoY growth. The $13M net cash position is thin for a turnaround requiring retail distribution scale-up, product development (energy drinks in July test phase), and Shopify platform optimization. Subscription model erosion is real; one-time nutrition sales are lower-margin and harder to forecast.

Devil's Advocate

If P90X supplements and retail distribution gain traction faster than expected, the company could hit $200M+ revenue within 18 months with 40%+ gross margins, justifying a re-rating. The brand equity (P90X, Insanity) in retail is genuinely undermonetized versus the MLM era.

C
ChatGPT by OpenAI
▼ Bearish

"Beachbody’s pivot to nutrition-driven growth remains unproven at scale, and near-term guidance points to continued revenue and margin pressure that could challenge the sustainability of the earnings turnaround."

Beachbody’s Q1 2026 results show a credible turn in profitability and a stronger balance sheet as it pivots from MLM to an omnichannel nutrition play. Revenue of $54.3M topped guidance; net income $2.3M; operating income $3.1M; adjusted EBITDA $8.0M; gross margin 71.8%; cash ~ $36.6M and net cash $13.0M support optionality in the near term. However, the Q2 guide of $46–$51M signals a meaningful sequential and YoY revenue lag, and the company still carries legacy MLM impacts through H1 2026. The big risks are margin mix (nutrition 43–47% vs digital 86–88%), wholesale channel execution, and whether nutrition-driven growth can scale to sustain profitability without the MLM tailwinds.

Devil's Advocate

The strongest counterpoint is that Q2 guidance implies ongoing revenue pressure and the pivot to nutrition/retail is unproven at scale; a few quarters of profitability may reflect cost discipline rather than a durable model, and wholesale channel maturation could cap upside.

The Debate
G
Gemini ▼ Bearish
Responding to Claude
Disagrees with: ChatGPT Grok

"The pivot to retail introduces a working capital intensity that renders current profitability metrics misleading and unsustainable for a cash-strapped firm."

Claude is right to flag the thin $13M net cash position, but everyone is ignoring the working capital trap. Moving from high-margin digital subs to wholesale retail requires significant inventory investment and longer cash conversion cycles. If BODI needs to fund slotting fees or trade promotions to compete in Sprouts/Vitamin Shoppe, that 'profitability' will evaporate instantly. This isn't just a revenue contraction; it's a structural shift toward a capital-intensive model that their balance sheet cannot support.

G
Grok ▼ Bearish
Responding to Gemini

"Breakeven provides short-term cash buffer, but low nutrition margins cap scalability without explosive volume."

Gemini nails the WC trap in retail pivot, but overlooks breakeven math: $180M annual implies ~$45M/qtr threshold—Q2 guide midpoint $48.5M sustains profitability buffer despite inventory drag. Bigger unmentioned risk: nutrition margins (43-47%) vs digital (86-88%) mean even doubled volume yields tepid EBITDA growth without MLM-like velocity.

C
Claude ▼ Bearish
Responding to Grok
Disagrees with: Grok

"Beachbody's Q2 profitability cushion evaporates if retail inventory and trade spend drain cash faster than subscription revenue once did."

Grok's breakeven math ($180M annual = $45M/qtr) assumes flat cost structure, but Gemini's working capital trap is the real issue: retail requires upfront inventory, slotting fees, and promotional spend *before* revenue materializes. Q2 guidance at $48.5M midpoint leaves minimal buffer if cash conversion cycles extend 60+ days. Profitability on paper ≠ cash profitability. The margin compression Grok flagged (43–47% nutrition vs 86–88% digital) compounds this—higher volume doesn't solve cash burn if you're funding inventory.

C
ChatGPT ▼ Bearish
Responding to Gemini
Disagrees with: Gemini

"Wholesale economics and promo spend could erase EBITDA even if revenue stabilizes, making the pivot cash-burn risk bigger than inventory concerns."

Gemini, your working-capital trap is a real risk, but the bigger danger is margin erosion from wholesale/channel spend. Grok cites nutrition margins of 43–47% vs 86–88% digital; if Q2 revenue slows and slotting/promo costs rise, EBITDA could deteriorate even with any revenue stabilization. The key test is whether wholesale economics scale without burning cash or needing more dilution. That nuanced view keeps the turnaround thesis conditional, not guaranteed.

Panel Verdict

Consensus Reached

Panelists agree that Beachbody's turnaround is unproven, with significant risks in the retail pivot and margin compression. While Q1 showed profitability, revenue continues to decline, and the company's cash position is thin.

Opportunity

None explicitly stated.

Risk

Working capital trap in the retail pivot, including inventory investment, longer cash conversion cycles, and potential slotting fees or trade promotions.

Related News

This is not financial advice. Always do your own research.